Regulation of morphogenesis in C. albicans
白色念珠菌形态发生的调控
基本信息
- 批准号:9312992
- 负责人:
- 金额:$ 22.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-02-01 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAmphotericinAntifungal AgentsAntifungal TherapyAntioxidantsAzolesCandida albicansCell WallCell membraneCellsComplexCopperCytoplasmic TailDefectDevelopmentDrug resistanceEffectivenessEnergy MetabolismEnvironmentExtracellular DomainFlavodoxinFluconazoleGene ProteinsGoalsGrantGrowthHigh temperature of physical objectHospitalsHumanImpairmentIndividualInfectionIntegral Membrane ProteinLipid PeroxidationLipid PeroxidesLipidsMammalian CellMediatingMedicalMembraneMembrane ProteinsMicrobial BiofilmsMitochondriaMorphogenesisMutagenesisMutationMycosesNutrientOrganOrganismOxidative StressPathogenesisPathogenicityPathway interactionsPeripheralPharmaceutical PreparationsPlayProcessProtein FamilyProteinsQuinone ReductasesRegulationResistanceRoleSERPINA4 geneSepsisStressSystemic infectionTemperatureTestingTherapeuticTherapeutic InterventionTimeTissuesTransmembrane DomainUbiquinoneVirulenceVirulence Factorsaging populationantimicrobial peptideextracellularfungusimprovedin vivomutantnew therapeutic targetnovelnovel therapeutic interventionoxidationpathogenpreventresistant strainrole modelsuccessuptake
项目摘要
Candida albicans is the most common cause of mucosal and systemic fungal infections in humans
and is frequently responsible for hospital-acquired bloodstream infections. There is an urgent need to
improve the therapeutic management of C. albicans infections, since current antifungal drugs have
limited effectiveness and drug-resistant strains are emerging. The pathogenic effects of C. albicans
are caused by its ability to grow in the host and disseminate to internal organs. Central to these
processes is the plasma membrane, an essential barrier that mediates a broad range of functions that
are critical for virulence. These functions include cell wall synthesis, secretion of virulence factors,
morphogenesis, and nutrient uptake. The importance of the plasma membrane for virulence is
underscored by the fact that it is directly or indirectly the target of the currently used antifungal drugs.
Recent studies have revealed that the fungal plasma membrane is divided into distinct subdomains,
including the punctate patches termed eisosomes. These 300 nm-sized domains contain integral
membrane proteins, such as Sur7, and an adjacent complex of >20 peripheral membrane proteins
including Pil1 and Lsp1 that promote formation of eisosomes. Our recent studies showed that Sur7,
Pil1, and Lsp1 are the key players in the eisosome, as their mutation causes multiple defects
including impaired cell wall synthesis, abnormal morphogenesis, and increased sensitivity to stress,
oxidation, and antifungal drugs. Therefore, the Aims of our current proposal are to determine how
eisosomes regulate three functions that are required for virulence: (Aim 1) cell wall synthesis and
invasive hyphal morphogenesis, (Aim 2) resistance to different types of stress including copper and
high temperature, and (Aim 3) a novel antioxidant pathway we discovered that protects the plasma
membrane from oxidation and is needed for virulence. The proposed studies will identify novel drug
targets and increase our understanding of the effects of current antifungal drugs. Defining eisosome
function in C. albicans will also provide a model for the role of these plasma membrane domains in
other pathogenic fungi.
白色念珠菌是人类粘膜和全身真菌感染的最常见原因
并且经常导致医院获得性血流感染。迫切需要
改善白色念珠菌感染的治疗管理,因为目前的抗真菌药物已
效果有限且耐药菌株不断出现。白色念珠菌的致病作用
是由于其在宿主体内生长并传播到内脏器官的能力引起的。这些的核心
质膜是介导多种功能的重要屏障,
对毒力至关重要。这些功能包括细胞壁合成、毒力因子的分泌、
形态发生和营养吸收。质膜对于毒力的重要性是
强调它是目前使用的抗真菌药物的直接或间接目标。
最近的研究表明,真菌质膜分为不同的子域,
包括称为 eisosomes 的点状斑块。这些 300 nm 大小的域包含积分
膜蛋白,例如 Sur7,以及超过 20 个外周膜蛋白的相邻复合物
包括促进 eisosome 形成的 Pil1 和 Lsp1。我们最近的研究表明 Sur7,
Pil1 和 Lsp1 是 eisosome 中的关键角色,因为它们的突变会导致多种缺陷
包括细胞壁合成受损、形态发生异常和对压力的敏感性增加,
抗氧化、抗真菌药物。因此,我们当前提案的目标是确定如何
eisosomes 调节毒力所需的三种功能:(目标 1)细胞壁合成和
侵入性菌丝形态发生,(目标 2)对不同类型的胁迫(包括铜和
高温,以及(目标 3)我们发现的一种新的抗氧化途径,可以保护血浆
膜免受氧化并且是毒力所必需的。拟议的研究将确定新药
目标并增加我们对当前抗真菌药物作用的了解。定义内切酶体
白色念珠菌中的功能也将为这些质膜结构域在
其他病原真菌。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James B Konopka其他文献
James B Konopka的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James B Konopka', 18)}}的其他基金
Signal pathways controlling the bud to hypha transition
控制芽到菌丝转变的信号通路
- 批准号:
9912167 - 财政年份:2015
- 资助金额:
$ 22.01万 - 项目类别:
Signal pathways controlling the bud to hypha transition
控制芽到菌丝转变的信号通路
- 批准号:
10406353 - 财政年份:2015
- 资助金额:
$ 22.01万 - 项目类别:
C. albicans invasive growth promotes oropharyngeal infections
白色念珠菌侵入性生长促进口咽部感染
- 批准号:
9014539 - 财政年份:2015
- 资助金额:
$ 22.01万 - 项目类别:
Signal pathways controlling the bud to hypha transition
控制芽到菌丝转变的信号通路
- 批准号:
9752694 - 财政年份:2015
- 资助金额:
$ 22.01万 - 项目类别:
相似国自然基金
构建递送两性霉素B的聚丝氨酸脂质纳米粒用于增强抗真菌感染治疗效果的研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
固醇衍生物Eldecalcitol对两性霉素B增效减毒活性及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向感染微环境的生物响应HBc-两性霉素B抗真菌作用机制研究
- 批准号:81903670
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
法尼基转移酶介导的烟曲霉对两性霉素B敏感性增加的机制
- 批准号:81571969
- 批准年份:2015
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Mapping the genomic and molecular mechanisms of antifungal resistance in the emerging fungal pathogen Candida auris
绘制新兴真菌病原体耳念珠菌抗真菌耐药性的基因组和分子机制
- 批准号:
10587792 - 财政年份:2023
- 资助金额:
$ 22.01万 - 项目类别:
Harnessing Polyketide Assembly Lines for Medicinal Chemistry
利用聚酮化合物装配线进行药物化学
- 批准号:
10651828 - 财政年份:2022
- 资助金额:
$ 22.01万 - 项目类别:
Development and evaluation of a second-generation fungerp for systemic and cutaneous C. auris infection
用于全身和皮肤耳念珠菌感染的第二代真菌的开发和评估
- 批准号:
10561860 - 财政年份:2022
- 资助金额:
$ 22.01万 - 项目类别:
Hit-to-lead optimization of broad spectrum antifungal phenothiazines
广谱抗真菌吩噻嗪类化合物的命中至先导化合物优化
- 批准号:
10416079 - 财政年份:2021
- 资助金额:
$ 22.01万 - 项目类别:
Host factors affecting susceptibility to Candida auris.
影响耳念珠菌易感性的宿主因素。
- 批准号:
10553153 - 财政年份:2021
- 资助金额:
$ 22.01万 - 项目类别: